Savara Inc. rose 1.32% in intraday trading, with the company announcing the acceptance of three abstracts for poster presentation at the European Respiratory Society (ERS) Congress 2025. The company will also host an Industry Evening Mini Symposium titled 'Advances in Autoimmune Pulmonary Alveolar Proteinosis' at the meeting.
Comments
No comments yet